BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, May 22, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

July 14, 2020

View Archived Issues
Deal-handshake-arrows-chalkboard.png

Edwards, Abbott enter settlement to wrap up patent litigation

Ongoing litigation between rivals Edwards Lifesciences Corp. and Abbott Laboratories is over, with the two settling all outstanding patent disputes in cases related to transcatheter mitral and tricuspid repair products. Details of the settlement remain confidential. Read More
Regulatory-US-FDA-HQ.png

FDA holds to minimum one-year of follow-up in prostate ablation studies guidance

The U.S. FDA has a number of draft guidances in queue thanks to the COVID-19 pandemic, but released two final guidances in mid-July, including the guidance for clinical investigations for prostate tissue ablation devices. Stakeholders pressed the agency to avoid a fixed period of follow-up for such studies due to variability in the elapsed time for device-related adverse events, but the agency stuck to the draft’s mandate for at least a year of follow-up. Read More
Child using Curesight

Novasight raises $8M to back vision care solutions

Novasight Ltd. has scooped up $8 million in a series A financing that’s intended to get the company through a pivotal study of its first U.S. indication, Curesight, as well as to advance other pipeline products. The Israeli startup is tackling a range of pediatric vision disorders using artificial intelligence and eye-tracking technology. Read More
Bryan Johnson stands next to device

Kernel pops $53M series C funding for brain recording technology

A new $53 million in series C venture financing has bolstered Kernel's funding to further develop the company's brain recording technology and neuroscience as a service (NaaS) platform. The round was led by General Catalyst along with Khosla Ventures, Eldridge, Manta Ray Ventures, Tiny Blue Dot, and Kernel's CEO and founder Bryan Johnson. Read More
europe-uk-flag.png

Review in U.K. finds that patient concerns have been ignored for decades with harmful consequences

LONDON – An independent U.K. inquiry has found that failure to take seriously concerns raised by patients has resulted in life-threatening problems caused by medical devices and drugs being ignored for decades. Read More

10x Genomics launches next-gen single cell immune profiling to support COVID-19 research

Researchers around the globe are still struggling to understand the basic biology of COVID-19 infection, including how it works in the body and how to most effectively combat it. To aid them in their efforts under the weight of the ongoing pandemic, single-cell research tool company 10x Genomics Inc. has launched an updated version of its Chromium Single Cell Immune Profiling product. Read More

Appointments and advancements for July 14, 2020

New hires and promotions in the med-tech industry, including: Accuvein, Atlantic Therapeutics, Beaufort, Penumbra, Predictive Oncology, Sight Sciences. Read More

Financings for July 14, 2020

Med-tech firms raising money in public or private financings, including: Abm Respiratory Care, Adapthealth, Aatru Medical, Cardiva Medical, Deep Longevity, Movano, Pattern Bioscience, Presidio Medical, Reapplix, Sirius Medical. Read More

Other news to note for July 14, 2020

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3M, Aatru Medical, Ashion Analytics, Avitecture, Biotricity, Breg, Caris Life Sciences, Diaceutics, Cosylab, Doctor Evidence, Helius Medical Technologies, Helix Opco, Histocyte Laboratories, I3 Biomedical, Intralink-Spine, Joint Operations, Lantos Technologies, Merus, Myndtec, Nemaura Medical, Omnihealth, Pi-Cardia, Proscia, Quartic.ai, Royal Philips, Saina Health, Sensus Healthcare, Sparta Systems, Speechvive, Targos Molecular Pathology, Venus Medtech, Verizon, Vipun Medical. Read More

Regulatory actions for July 14, 2020

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Avicenna.AI, Corneat Vision, Dante Labs, GI Supply, Hd Medical, Qubyx, Revamp Medical, Vela Diagnostics, Vitls, Viveve. Read More

Regulatory front for July 14, 2020

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Glaukos, Greiner, Ortho-Clinical. Read More

BioWorld MedTech’s Oncology Extra for July 14, 2020

Keeping you up to date on recent developments in oncology, including: Single-cell RNA sequencing sheds new light on ependymoma in pediatric patients; Immunicom, Sheba Medical team up on immunopheresis for cancer; New study confirms link between infarct, cancer mortality. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 21, 2026.
  • Acid alpha-glucosidase molecular structure isolated on black

    ‘Detargeted’ targeted gene therapy improves activity in Pompe

    BioWorld
    A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 19, 2026
  • Microscopic view of the ebola virus

    WHO declares Ebola outbreak a public health emergency of international concern

    BioWorld
    The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
  • Nxera Pharma prepares and tests new GPR17 antagonists

    BioWorld Science
    Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing